Therapeutics: G protein pathway suppressor 2 (GPRS2)

Endocrine/metabolic disease

INDICATION: Obesity; diabetes

Patient sample and mouse studies suggest GPRS2 could help treat

Read the full 139 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE